- Home
- RVTY vs ENSG Comparison
RVTY vs ENSG Comparison
Compare RVTY & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | ENSG |
|---|---|---|
| Founded | 1937 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Hospital/Nursing Management |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.0B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RVTY | ENSG |
|---|---|---|
| Price | $98.99 | $165.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 5 |
| Target Price | $109.67 | ★ $202.60 |
| AVG Volume (30 Days) | ★ 1.6M | 519.8K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.34% | 0.14% |
| EPS Growth | N/A | ★ 14.06 |
| EPS | 0.36 | ★ 1.67 |
| Revenue | $3,311,822,000.00 | ★ $5,057,841,000.00 |
| Revenue This Year | $6.37 | $17.07 |
| Revenue Next Year | $5.10 | $9.49 |
| P/E Ratio | $279.22 | ★ $98.80 |
| Revenue Growth | N/A | ★ 18.72 |
| 52 Week Low | $81.22 | $134.80 |
| 52 Week High | $118.30 | $218.00 |
Technical Indicators
Market Signals| Indicator | RVTY | ENSG |
|---|---|---|
| Relative Strength Index (RSI) | 54.80 | 27.60 |
| Support Level | $94.04 | N/A |
| Resistance Level | $102.16 | $181.79 |
| Average True Range (ATR) | 3.25 | 3.84 |
| MACD | 0.29 | -0.28 |
| Stochastic Oscillator | 46.90 | 9.53 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.